CPIX: Cumberland Pharma Kompaniya qiymatining sof foydaga nisbati

Cumberland Pharmaceuticals Inc (CPIX) korporativ emblemasi va logotipi

Cumberland Pharmaceuticals (CPIX) AQSh shifoxonalar sektorining tan olingan yetakchisi bo'lib, o'zining antidotlari va anesteziya vositalarining murosasiz sifati orqali klinikalarning ishonchini qozongan. GURU.Markets platformasidagi ushbu grafikda tasdiqlangan va indikator -7.40 qiymatida turgan narxlar tarixi xomashyo yetishmovchiligini bartaraf etuvchi ishlab chiqarish autsorsing modeliga asoslangan. Biznesning o'sishi FDA tasdiqlari ro'yxatini kengaytirishga hamda Vibativ va Vaprisol kabi samarali dori vositalarini tijoratlashtirishga tayanadi.

CPIX Cumberland Corp: Narx-foyda koeffitsiyenti 04.07.2022 - 14.11.2026 oraligʻida

Cumberland Pharmaceuticals Inc (CPIX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Cumberland Pharma|CPIX - Konsensus maqsadli narx
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati Cumberland Pharma|CPIX - Kompaniyaning to‘liq qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Cumberland Pharmaceuticals|CPIX - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori cumberlandpharma.com|CPIX - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Cumberland Pharmaceuticals|CPIX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati cumberlandpharma.com|CPIX - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Cumberland Pharmaceuticals Inc|CPIX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Cumberland Pharmaceuticals|Tezkor likvidlik koeffitsiyenti cumberlandpharma.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CPIX - Kompaniyaning sof foydasi|Kelajakdagi foyda Cumberland Pharmaceuticals|CPIX - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Cumberland Pharma|CPIX - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Cumberland Pharma|CPIX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Cumberland Pharmaceuticals|CPIX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi cumberlandpharma.com|CPIX - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Cumberland Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
CPIX - Kompaniya daromadi|Kompaniya daromadi prognozi Cumberland Pharmaceuticals Inc.|CPIX - P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Cumberland Corp
Kompaniyaning har tomonlama tahlili:Cumberland Pharmaceuticals Inc. - CPIX
Cumberland Pharmaceuticals Inc. yetakchi tovari

Bozor kapitalizatsiyasining har bir aksiya uchun foyda ko'rsatkichiga nisbati kapitalning qoplanish muddatini belgilaydi va aktiv narxining uning haqiqiy daromadiga nisbatan samaradorligini o'lchaydi. Cumberland Pharmaceuticals (CPIX) uchun ushbu hisob-kitob biznesning barqarorligini aks ettiradi, bunda shifoxonalarga eksklyuziv yetkazib berish huquqlari generik dori vositalarining ta'sirini minimallashtiradi va investorlarga kompaniyaning foyda ko'paytirgichi orqali fundamental past baholanganlikni baholash imkonini beradi.

Muhim raqobatchilar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|HYFT: Narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Narxning foydaga nisbati|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)